A detailed history of Signaturefd, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Signaturefd, LLC holds 1,050 shares of AVXL stock, worth $9,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,050
Previous 183 473.77%
Holding current value
$9,492
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$4.11 - $7.04 $3,563 - $6,103
867 Added 473.77%
1,050 $5,000
Q2 2024

Jul 29, 2024

SELL
$3.39 - $5.02 $335 - $496
-99 Reduced 35.11%
183 $0
Q1 2024

May 03, 2024

SELL
$4.55 - $6.75 $850 - $1,262
-187 Reduced 39.87%
282 $1,000
Q4 2023

Jan 31, 2024

BUY
$5.04 - $9.95 $2,363 - $4,666
469 New
469 $4,000
Q2 2022

Aug 10, 2022

BUY
$7.31 - $12.84 $36 - $64
5 Added 50.0%
15 $0
Q4 2021

Jan 25, 2022

BUY
$16.88 - $23.31 $168 - $233
10 New
10 $0

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $705M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.